Loy Bertrand's Insider Trades & SAST Disclosures
Loy Bertrand's most recent trade in Entegris Inc was a trade of 4,619 Common Stock done at an average price of $65.4 . Disclosure was reported to the exchange on April 5, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Loy Bertrand.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Entegris Inc | Bertrand Loy | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.39 per share. | 05 Apr 2025 | 4,619 | 305,820 (0%) | 0% | 65.4 | 302,036 | Common Stock |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 96,812 | 96,812 | - | - | Employee Stock Option (Right to Buy) | |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 54,060 | 310,439 (0%) | 0% | 0 | Common Stock | |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 107.99 per share. | 20 Feb 2025 | 12,932 | 256,680 (0%) | 0% | 108.0 | 1,396,527 | Common Stock |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 12,671 | 275,739 (0%) | 0% | 0 | Common Stock | |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 107.99 per share. | 19 Feb 2025 | 6,127 | 269,612 (0%) | 0% | 108.0 | 661,655 | Common Stock |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.10 per share. | 03 Jul 2024 | 27,044 | 290,112 (0%) | 0% | 31.1 | 841,068 | Common Stock |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jul 2024 | 27,044 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 140.29 per share. | 03 Jul 2024 | 19,509 | 270,603 (0%) | 0% | 140.3 | 2,736,918 | Common Stock |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 141.46 per share. | 03 Jul 2024 | 7,035 | 263,568 (0%) | 0% | 141.5 | 995,171 | Common Stock |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 142.12 per share. | 03 Jul 2024 | 500 | 263,068 (0%) | 0% | 142.1 | 71,060 | Common Stock |
| Harvard Bioscience Inc. | Bertrand Loy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 56,575 | 56,575 (0%) | 0% | 0 | Common Stock | |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 65,880 | 65,880 | - | - | Employee Stock Option (Right to Buy) | |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 38,208 | 263,068 (0%) | 0% | 0 | Common Stock | |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 20,534 | 233,967 (0%) | 0% | 0 | Common Stock | |
| Entegris Inc | Loy Bertrand | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 136.81 per share. | 16 Feb 2024 | 15,756 | 213,433 (0%) | 0% | 136.8 | 2,155,578 | Common Stock |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 136.81 per share. | 16 Feb 2024 | 9,107 | 224,860 (0%) | 0% | 136.8 | 1,245,929 | Common Stock |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 95.87 per share. | 15 Aug 2023 | 9,357 | 229,189 (0%) | 0% | 95.9 | 897,056 | Common Stock |
| Harvard Bioscience Inc. | Bertrand Loy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2023 | 31,516 | 79,009 (0%) | 0% | 0 | Common Stock | |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.48 per share. | 17 Feb 2023 | 14,126 | 238,546 (0%) | 0% | 85.5 | 1,207,490 | Common Stock |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 19,676 | 261,399 (0%) | 0% | 0 | Common Stock | |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.94 per share. | 13 Feb 2023 | 8,727 | 252,672 (0%) | 0% | 84.9 | 741,271 | Common Stock |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 91,704 | 91,704 | - | - | Employee Stock Option (Right to Buy) | |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 51,292 | 241,723 (0%) | 0% | 0 | Common Stock | |
| Harvard Bioscience Inc. | Bertrand Loy | Director | Other type of transaction at price $ 0.00 per share. | 06 Sep 2022 | 108,715 | 0 (0%) | 0% | 0 | Common Stock | |
| Harvard Bioscience Inc. | Bertrand Loy | Director | Purchase of securities on an exchange or from another person at price $ 3.41 per share. | 26 Aug 2022 | 9,291 | 399,651 (1%) | 0% | 3.4 | 31,682 | Common Stock |
| Harvard Bioscience Inc. | Bertrand Loy | Director | Purchase of securities on an exchange or from another person at price $ 3.23 per share. | 24 Aug 2022 | 17,291 | 382,116 (1%) | 0% | 3.2 | 55,850 | Common Stock |
| Harvard Bioscience Inc. | Bertrand Loy | Director | Purchase of securities on an exchange or from another person at price $ 3.34 per share. | 24 Aug 2022 | 8,244 | 390,360 (1%) | 0% | 3.3 | 27,535 | Common Stock |
| Harvard Bioscience Inc. | Bertrand Loy | Director | Purchase of securities on an exchange or from another person at price $ 3.23 per share. | 22 Aug 2022 | 8,939 | 364,825 (0%) | 0% | 3.2 | 28,873 | Common Stock |
| Harvard Bioscience Inc. | Bertrand Loy | Director | Purchase of securities on an exchange or from another person at price $ 3.16 per share. | 22 Aug 2022 | 4,918 | 355,886 (0%) | 0% | 3.2 | 15,541 | Common Stock |
| Harvard Bioscience Inc. | Bertrand Loy | Director | Purchase of securities on an exchange or from another person at price $ 3.28 per share. | 18 Aug 2022 | 9,608 | 350,968 (0%) | 0% | 3.3 | 31,514 | Common Stock |
| Harvard Bioscience Inc. | Bertrand Loy | Director | Purchase of securities on an exchange or from another person at price $ 3.19 per share. | 18 Aug 2022 | 1,151 | 341,360 (0%) | 0% | 3.2 | 3,672 | Common Stock |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.39 per share. | 15 Aug 2022 | 9,357 | 190,431 (0%) | 0% | 105.4 | 986,134 | Common Stock |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jul 2022 | 116 | 199,788 (0%) | 0% | - | Common Stock | |
| Harvard Bioscience Inc. | Bertrand Loy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 47,493 | 340,209 (0%) | 0% | 0 | Common Stock | |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 130.19 per share. | 18 Feb 2022 | 15,043 | 199,672 (0%) | 0% | 130.2 | 1,958,448 | Common Stock |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 24,020 | 225,368 (0%) | 0% | 0 | Common Stock | |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 124.48 per share. | 11 Feb 2022 | 10,653 | 214,715 (0%) | 0% | 124.5 | 1,326,085 | Common Stock |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 60,392 | 60,392 | - | - | Employee Stock Option (Right to Buy) | |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 27,248 | 201,348 (0%) | 0% | 0 | Common Stock | |
| Harvard Bioscience Inc. | Bertrand Loy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2022 | 4,489 | 292,716 (0%) | 0% | 0 | Common Stock | |
| Harvard Bioscience Inc. | Bertrand Loy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Dec 2021 | 1,401 | 288,227 (0%) | 0% | 0 | Common Stock | |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 119.87 per share. | 09 Aug 2021 | 53,759 | 34,951 (0%) | 0% | 119.9 | 6,444,167 | Common Stock |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 121.66 per share. | 09 Aug 2021 | 47,225 | 89,010 (0%) | 0% | 121.7 | 5,745,209 | Common Stock |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 121.03 per share. | 09 Aug 2021 | 17,475 | 136,235 (0%) | 0% | 121.0 | 2,115,011 | Common Stock |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 120.74 per share. | 09 Aug 2021 | 10,441 | 24,510 (0%) | 0% | 120.7 | 1,260,672 | Common Stock |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 121.65 per share. | 09 Aug 2021 | 7,074 | 174,100 (0%) | 0% | 121.7 | 860,570 | Common Stock |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 121.01 per share. | 09 Aug 2021 | 2,732 | 181,174 (0%) | 0% | 121.0 | 330,604 | Common Stock |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 121.64 per share. | 09 Aug 2021 | 800 | 23,710 (0%) | 0% | 121.6 | 97,309 | Common Stock |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 122.86 per share. | 09 Aug 2021 | 300 | 88,710 (0%) | 0% | 122.9 | 36,858 | Common Stock |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 125.41 per share. | 04 Aug 2021 | 37,178 | 155,710 (0%) | 0% | 125.4 | 4,662,456 | Common Stock |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 125.38 per share. | 04 Aug 2021 | 16,100 | 184,806 (0%) | 0% | 125.4 | 2,018,591 | Common Stock |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 126.10 per share. | 04 Aug 2021 | 2,000 | 153,710 (0%) | 0% | 126.1 | 252,209 | Common Stock |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 126.12 per share. | 04 Aug 2021 | 900 | 183,906 (0%) | 0% | 126.1 | 113,511 | Common Stock |
| Harvard Bioscience Inc. | Bertrand Loy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 14,400 | 286,826 (0%) | 0% | 0 | Common Stock | |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 119.47 per share. | 12 Apr 2021 | 82,110 | 404,144 (0%) | 0% | 119.5 | 9,809,517 | Common Stock |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 117.82 per share. | 12 Apr 2021 | 62,372 | 334,859 (0%) | 0% | 117.8 | 7,348,544 | Common Stock |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 118.51 per share. | 12 Apr 2021 | 58,055 | 216,059 (0%) | 0% | 118.5 | 6,879,866 | Common Stock |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 118.22 per share. | 12 Apr 2021 | 30,153 | 304,706 (0%) | 0% | 118.2 | 3,564,808 | Common Stock |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 117.78 per share. | 12 Apr 2021 | 26,792 | 274,114 (0%) | 0% | 117.8 | 3,155,642 | Common Stock |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 119.29 per share. | 12 Apr 2021 | 15,153 | 200,906 (0%) | 0% | 119.3 | 1,807,541 | Common Stock |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 118.54 per share. | 12 Apr 2021 | 14,652 | 486,254 (0%) | 0% | 118.5 | 1,736,892 | Common Stock |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 116.56 per share. | 12 Apr 2021 | 3,675 | 397,231 (0%) | 0% | 116.6 | 428,351 | Common Stock |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 119.46 per share. | 12 Apr 2021 | 3,400 | 301,306 (0%) | 0% | 119.5 | 406,167 | Common Stock |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 120.11 per share. | 12 Apr 2021 | 2,838 | 401,306 (0%) | 0% | 120.1 | 340,858 | Common Stock |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 120.52 per share. | 12 Apr 2021 | 400 | 300,906 (0%) | 0% | 120.5 | 48,208 | Common Stock |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 120.96 per share. | 12 Apr 2021 | 400 | 400,906 (0%) | 0% | 121.0 | 48,384 | Common Stock |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 120.53 per share. | 05 Apr 2021 | 196,476 | 571,211 (0%) | 0% | 120.5 | 23,680,270 | Common Stock |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2021 | 139,992 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.60 per share. | 05 Apr 2021 | 139,992 | 640,898 (0%) | 0% | 21.6 | 3,023,827 | Common Stock |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2021 | 81,132 | 27,044 | - | - | Employee Stock Option (Right to Buy) | |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.10 per share. | 05 Apr 2021 | 81,132 | 722,030 (0%) | 0% | 31.1 | 2,523,205 | Common Stock |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2021 | 57,570 | 57,570 | - | - | Employee Stock Option (Right to Buy) | |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.33 per share. | 05 Apr 2021 | 57,570 | 779,600 (0%) | 0% | 33.3 | 1,918,808 | Common Stock |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 121.21 per share. | 05 Apr 2021 | 49,326 | 521,885 (0%) | 0% | 121.2 | 5,978,755 | Common Stock |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 119.45 per share. | 05 Apr 2021 | 33,663 | 767,687 (0%) | 0% | 119.4 | 4,020,944 | Common Stock |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2021 | 21,750 | 65,250 | - | - | Employee Stock Option (Right to Buy) | |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 55.72 per share. | 05 Apr 2021 | 21,750 | 801,350 (0%) | 0% | 55.7 | 1,211,910 | Common Stock |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 122.20 per share. | 05 Apr 2021 | 14,264 | 507,621 (0%) | 0% | 122.2 | 1,743,018 | Common Stock |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 123.26 per share. | 05 Apr 2021 | 2,863 | 504,758 (0%) | 0% | 123.3 | 352,905 | Common Stock |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 125.99 per share. | 05 Apr 2021 | 2,400 | 500,906 (0%) | 0% | 126.0 | 302,378 | Common Stock |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 125.01 per share. | 05 Apr 2021 | 1,452 | 503,306 (0%) | 0% | 125.0 | 181,512 | Common Stock |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2021 | 23,428 | 528,071 (0%) | 0% | 0 | Common Stock | |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.57 per share. | 19 Feb 2021 | 16,774 | 500,906 (0%) | 0% | 105.6 | 1,770,831 | Common Stock |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.57 per share. | 19 Feb 2021 | 10,391 | 517,680 (0%) | 0% | 105.6 | 1,096,978 | Common Stock |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2021 | 71,372 | 71,372 | - | - | Employee Stock Option (Right to Buy) | |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2021 | 29,760 | 504,643 (0%) | 0% | 0 | Common Stock | |
| Harvard Bioscience Inc. | Bertrand Loy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 21,300 | 272,426 (0%) | 0% | 0 | Common Stock | |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Sep 2020 | 101,888 | 474,883 (0%) | 0% | 0 | Common Stock | |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Sep 2020 | 101,888 | 192,888 (0%) | 0% | 0 | Common Stock | |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.20 per share. | 30 Jul 2020 | 257,928 | 834,699 (0%) | 0% | 12.2 | 3,146,722 | Common Stock |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jul 2020 | 257,928 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.00 per share. | 30 Jul 2020 | 139,408 | 695,291 (0%) | 0% | 70 | 9,758,560 | Common Stock |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 71.72 per share. | 30 Jul 2020 | 104,477 | 590,814 (0%) | 0% | 71.7 | 7,492,881 | Common Stock |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 72.37 per share. | 30 Jul 2020 | 14,043 | 576,771 (0%) | 0% | 72.4 | 1,016,264 | Common Stock |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2020 | 42,194 | 576,771 (0%) | 0% | 0 | Common Stock | |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.49 per share. | 24 Jul 2020 | 170,988 | 705,565 (0%) | 0% | 13.5 | 2,306,628 | Common Stock |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jul 2020 | 170,988 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 67.44 per share. | 24 Jul 2020 | 95,045 | 610,520 (0%) | 0% | 67.4 | 6,409,835 | Common Stock |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 69.73 per share. | 24 Jul 2020 | 66,942 | 534,727 (0%) | 0% | 69.7 | 4,667,866 | Common Stock |
| Entegris Inc | Bertrand Loy | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 68.97 per share. | 24 Jul 2020 | 8,851 | 601,669 (0%) | 0% | 69.0 | 610,453 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges